Back to search
FDAFDA · Food and drugs·Recall number Z-1592-2024

Actim PROM dipstik, REF 30831ETUS; qualitative immunoassay rapid test for rupture of fetal membrane

Published April 24, 2024 · Recall initiated: November 23, 2023

Summary

FDA records medical device Class II recall Z-1592-2024, published April 24, 2024 and initiated November 23, 2023. Recalling firm: ACTIM OY; Status: Ongoing; Reported quantity: 6471 kits; Lot: UDI/DI 06430030990608, All serial numbers in distribution. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Interference testing has shown that the presence of personal lubricants in the vaginal specimen can interfere with the PROM test result by providing a false positive result.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
ACTIM OY
Distributor
US Nationwide distribution in the state of Connecticut.
Lot
UDI/DI 06430030990608, All serial numbers in distribution
Risk classification
Class II
Area (FDA)
device
Country
Finland

Related recalls

Questions about this recall

Was Actim PROM dipstik, REF 30831ETUS; qualitative immunoassay rapid test for rupture of fetal membrane recalled?

Yes. FDA published recall Z-1592-2024 on April 24, 2024. Reported hazard: Interference testing has shown that the presence of personal lubricants in the vaginal specimen can interfere with the PROM test result by providing a false positive result.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail